JP Morgan Is Neutral On KND

Analysts at J.P. Morgan, this morning, issued a Neutral rating on shares of Kindred Healthcare (

), as well as established an $18 price target. According J.P. Morgan, one of the major risks moving forward is the "further deterioration in state tax revenues resulting in further Medicaid pressure," which would inhibit the ability of the company to meet Street estimates. Kindred Healthcare, Inc. operates as a healthcare services company in the United States. It operates in three divisions: Hospital, Health Services, and Rehabilitation.